Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Change in Receivables (2016 - 2024)

Historic Change in Receivables for HealthLynked (HLYK) over the last 9 years, with Q4 2024 value amounting to -$25557.0.

  • HealthLynked's Change in Receivables fell 2367.89% to -$25557.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$20861.0, marking a year-over-year increase of 2785.66%. This contributed to the annual value of -$20861.0 for FY2024, which is 2785.66% up from last year.
  • Per HealthLynked's latest filing, its Change in Receivables stood at -$25557.0 for Q4 2024, which was down 2367.89% from -$13002.0 recorded in Q3 2024.
  • In the past 5 years, HealthLynked's Change in Receivables registered a high of $38152.0 during Q1 2021, and its lowest value of -$106592.0 during Q4 2020.
  • Its 5-year average for Change in Receivables is -$7897.5, with a median of -$7678.5 in 2020.
  • The largest annual percentage gain for HealthLynked's Change in Receivables in the last 5 years was 167336.62% (2024), contrasted with its biggest fall of 55911.02% (2024).
  • Quarter analysis of 5 years shows HealthLynked's Change in Receivables stood at -$106592.0 in 2020, then skyrocketed by 89.49% to -$11199.0 in 2021, then surged by 175.26% to $8428.0 in 2022, then plummeted by 345.18% to -$20664.0 in 2023, then decreased by 23.68% to -$25557.0 in 2024.
  • Its Change in Receivables stands at -$25557.0 for Q4 2024, versus -$13002.0 for Q3 2024 and $4938.0 for Q2 2024.